SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,854.87 63.60
(0.12%)

Dow Jones

7,820.53 51.03
(0.66%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.37 0.00
(0.00%)

EUR-INR

110.01 -0.06
(-0.05%)

GBP-INR

128.81 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

75.32

225648.29

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.35

Back

Divi's Laboratories consolidated net profit rises 65.50% in the June 2026 quarter

Aug 01,2026

Net profit of Divi's Laboratories rose 65.50% to Rs 902.00 crore in the quarter ended June 2026 as against Rs 545.00 crore during the previous quarter ended June 2025. Sales rose 27.80% to Rs 3080.00 crore in the quarter ended June 2026 as against Rs 2410.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3080.00	2410.00	28
OPM %	40.75	30.25	-
PBDT	1313.00	845.00	55
PBT	1180.00	733.00	61
NP	902.00	545.00	66

78,009.25 -70.71 ( -0.09%)

53,854.87 63.60 (0.12%)

7,820.53 51.03 (0.66%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.37 0.00 (0.00%)

110.01 -0.06 (-0.05%)

128.81 0.00 (0.00%)

0.60 0.00 (-0.04%)